Allworth Financial LP Castle Biosciences Inc Transaction History

Allworth Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$13.28 - $20.3 $438 - $669	-33 Reduced 44.59%	41 $0
Q2 2023 Jul 18, 2023	SELL	$11.66 - $26.0 $664 - $1,482	-57 Reduced 43.51%	74 $1,000
Q1 2023 Apr 18, 2023	BUY	$19.47 - $28.49 $2,394 - $3,504	123 Added 1537.5%	131 $2,000
Q2 2022 Jul 13, 2022	BUY	$16.0 - $45.99 $128 - $367	8 New	8 $0

210

26.6M

128K

35.4K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $539M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.